Judge warns ‘enough’s enough’ in fight for damages over delayed Abilify generic

Allens 2021-06-03 10:52 am By Cat Fredenburgh | Melbourne

Please login to bookmark

A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au